ADL
NVO

Asset Dedication LLC’s Novo Nordisk NVO Stock Holding History

Asset Dedication LLC’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.2K Buy
1,924
+319
+20% +$13.7K 0.01% 415
2026
Q1 		$59K Sell
1,605
-150
-9% -$7.11K ﹤0.01% 457
2025
Q4 		$89.3K Sell
1,755
-610
-26% -$31.2K 0.01% 410
2025
Q3 		$131K Hold
2,365
– – 0.01% 387
2025
Q2 		$163K Sell
2,365
-12
-0.5% -$816 0.01% 351
2025
Q1 		$165K Buy
2,377
+12
+0.5% +$991 0.01% 317
2024
Q4 		$203K Buy
2,365
+11
+0.5% +$1.19K 0.02% 297
2024
Q3 		$280K Buy
2,354
+440
+23% +$58.7K 0.02% 285
2024
Q2 		$273K Hold
1,914
– – 0.02% 288
2024
Q1 		$246K Hold
1,914
– – 0.02% 280
2023
Q4 		$198K Hold
1,914
– – 0.02% 295
2023
Q3 		$174K Sell
1,914
-800
-29% -$70.5K 0.01% 305
2023
Q2 		$219K Buy
2,714
+800
+42% +$65.4K 0.02% 290
2023
Q1 		$151K Hold
1,914
– – 0.01% 325
2022
Q4 		$129K Hold
1,914
– – 0.01% 342
2022
Q3 		$96K Buy
+1,914
New +$103K 0.01% 346
2022
Q2 		– Sell
-1,914
Closed -$106K – 818
2022
Q1 		$106K Hold
1,914
– – 0.01% 349
2021
Q4 		$107K Hold
1,914
– – 0.01% 323
2021
Q3 		$91K Buy
1,914
+320
+20% +$15.5K 0.01% 331
2021
Q2 		$67K Buy
1,594
+76
+5% +$2.95K 0.01% 354
2021
Q1 		$51K Buy
1,518
+1,442
+1,897% +$51.4K 0.01% 331
2020
Q4 		$3K Hold
76
– – ﹤0.01% 678
2020
Q3 		$3K Buy
+76
New +$2.53K ﹤0.01% 646
2018
Q3 		– Sell
-2
Closed – – 731
2018
Q2 		$0 Buy
+2
New +$48 ﹤0.01% 709
2017
Q1 		– Sell
-594
Closed -$11K – 388
2016
Q4 		$11K Sell
594
-576
-49% -$10.4K 0.01% 296
2016
Q3 		$24K Sell
1,170
-1,414
-55% -$35.1K 0.02% 238
2016
Q2 		$69K Hold
2,584
– – 0.05% 173
2016
Q1 		$70K Sell
2,584
-1,380
-35% -$37K 0.05% 161
2015
Q4 		$115K Buy
+3,964
New +$110K 0.08% 171

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Asset Dedication LLC's NVO Position: Q2 2026 in Review

Asset Dedication LLC increased its Novo Nordisk (NVO) stake by 20% in Q2 2026, buying an estimated $13.7K and bringing the position to 1,924 shares worth $92.2K. The position accounts for 0.01% of the portfolio, ranked #415.

Asset Dedication LLC first reported a position in NVO in Q4 2015 and has held it in 29 quarters since. The position peaked at $280K in Q3 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Asset Dedication LLC held 1,924 shares of Novo Nordisk worth $92.2K as of Q2 2026.
  • Asset Dedication LLC bought 319 Novo Nordisk shares in Q2 2026, an estimated $13.7K.
  • Novo Nordisk made up 0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #415 holding.
  • Asset Dedication LLC first reported a position in Novo Nordisk in Q4 2015 and has held it in 29 quarters since.
  • Asset Dedication LLC's Novo Nordisk position peaked at $280K in Q3 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.